Epilepsy Trial, Recruiting (NCT06105645)

Epilepsy Trial, Recruiting NCT06105645 Sponsor: University Hospital, Toulouse Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06105645 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication (called drug-resistant focal epilepsy), as defined by the International League Against Epilepsy, and you are already scheduled to have a brain monitoring procedure called SEEG (where small electrodes are placed in the brain to find the source of seizures), which was approved by a specialist team
You have agreed in writing to allow your data to be collected for this study
You are covered by the French healthcare system

Who may not be able to join:

You are currently under a form of legal protection, such as having a legal guardian, curator, or being under court-supervised protection (confirm with trial site)
You are currently not free due to a legal or official government decision (for example, you are detained or imprisoned)
You have a heart defibrillator (an implanted device that regulates your heartbeat)
There are plans to use a heat-based treatment called thermocoagulation on any of the special electrodes being used in this study (confirm with trial site)
You are currently taking part in another clinical study that has a restriction on joining additional studies

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luc VALTON, MD, University Hospital, Toulouse

Phone: 0561775608

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06105645

Sponsor: University Hospital, Toulouse

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 0561775608

More information: https://clinicaltrials.gov/study/NCT06105645

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication (called drug-resistant focal epilepsy), as defined by the International League Against Epilepsy, and you are already scheduled to have a brain monitoring procedure called SEEG (where small electrodes are placed in the brain to find the source of seizures), which was approved by a specialist team
You have agreed in writing to allow your data to be collected for this study
You are covered by the French healthcare system

Who may not be able to join:

You are currently under a form of legal protection, such as having a legal guardian, curator, or being under court-supervised protection (confirm with trial site)
You are currently not free due to a legal or official government decision (for example, you are detained or imprisoned)
You have a heart defibrillator (an implanted device that regulates your heartbeat)
There are plans to use a heat-based treatment called thermocoagulation on any of the special electrodes being used in this study (confirm with trial site)
You are currently taking part in another clinical study that has a restriction on joining additional studies

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Toulouse

Registry

ClinicalTrials.gov

Start date

19 January 2024

Est. completion

1 April 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Contribution of fast-ripples information on freedom seizures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov